Evidence map›Paper›PMID 39317969›Full record

ArticleJournal of chemical information and modeling2024

Mothra: Multiobjective

Takamasa Suzuki, Dian Ma, Nobuaki Yasuo, Masakazu Sekijima

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. DrugGym: A testbed for the economics of autonomous drug discovery.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takamasa SuzukiDepartment of Computer Science, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8501Japan.ORCID 0009-0001-7567-2827
Dian MaDepartment of Computer Science, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8501Japan.
Nobuaki YasuoTokyo Tech Academy for Convergence of Materials and Informatics (TAC-MI), Tokyo Institute of Technology, Tokyo 152-8550, Japan.ORCID 0000-0002-3114-7895
Masakazu SekijimaDepartment of Computer Science, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8501Japan.ORCID 0000-0002-3806-9535

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the field of drug discovery, identifying compounds that satisfy multiple criteria, such as target protein affinity, pharmacokinetics, and membrane permeability, is challenging because of the vast chemical space. Until now, multiobjective optimization via generative models has often involved linear combinations of different reward functions. Linear combinations solve multiobjective optimization problems by turning multiobjective optimization into a single-objective task and causing problems with weighting for each objective. Herein, we propose a scalable multiobjective molecular generative model developed using deep learning techniques. This model integrates the capabilities of recurrent neural networks for molecular generation and Pareto multiobjective Monte Carlo tree search to determine the optimal search direction. Through this integration, our model can generate compounds using enhanced evaluation functions that include important aspects like target protein affinity, drug similarity, and toxicity. The proposed model addresses the limitations of previous linear combination methods, and its effectiveness is demonstrated via extensive experimentation. The improvements achieved in the evaluation metrics underscore the potential utility of our approach toward drug discovery applications. In addition, we provide the source code for our model such that researchers can easily access and use our framework in their own investigations. The source code and pretrained model for Mothra, developed in this study, along with the Docker image for the Pareto front explorer and compound picker, designed to streamline the selection and visualization of optimal chemical compounds, are released under the GNU General Public License v3.0 and available at https://github.com/sekijima-lab/Mothra.

Indexed as

Drug DiscoveryMonte Carlo MethodAlgorithmsDeep LearningModels, MolecularNeural Networks, Computer

Identifiers

PMID39317969
PMCPMC11481094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.